Gilead (GILD), Amgen (AMGN) and Vertex Pharmaceuticals (VRTX) are some of the most trending stocks in the biotech sector. See how they compare to other companies such as Biogen (BIIB), Illumina (ILMN) and Regeneron (REGN).
Comparison Results
Name | Price | Price Change | Analyst Price Target | Market Cap | Yearly Gain | Analyst Consensus | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|
Gilead Sciences | $62.86 | $72.43 (15.22% Upside) | $78.79B | -7.50% | 5 Buy 10 Hold 0 Sell Moderate Buy | premium | ||
Amgen | $226.97 | $235.40 (3.71% Upside) | $121.41B | 9.77% | 3 Buy 7 Hold 2 Sell Hold | premium | ||
Vertex Pharmaceuticals | $283.45 | $299.00 (5.49% Upside) | $72.69B | 54.38% | 8 Buy 6 Hold 0 Sell Moderate Buy | premium | ||
Biogen | $197.78 | $232.53 (17.57% Upside) | $28.70B | -32.20% | 9 Buy 9 Hold 0 Sell Moderate Buy | premium | ||
Illumina | $190.38 | $252.92 (32.85% Upside) | $29.95B | -56.01% | 4 Buy 8 Hold 2 Sell Hold | premium | ||
Regeneron | $697.33 | $760.67 (9.08% Upside) | $76.01B | 9.14% | 11 Buy 8 Hold 0 Sell Moderate Buy | premium | ||
Moderna | $123.64 | $214.63 (73.59% Upside) | $48.37B | -71.25% | 5 Buy 4 Hold 1 Sell Moderate Buy | premium | ||
IQVIA Holdings | $189.43 | $270.50 (42.80% Upside) | $35.33B | -27.59% | 12 Buy 0 Hold 0 Sell Strong Buy | premium | ||
Mettler-Toledo | $1132.01 | $1,314.20 (16.09% Upside) | $25.48B | -27.29% | 1 Buy 2 Hold 2 Sell Hold | premium | ||
BioNTech SE | $128.35 | $211.00 (64.39% Upside) | $31.15B | -61.14% | 4 Buy 6 Hold 0 Sell Moderate Buy | premium |
Performance Comparison
Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.
Recent Analysts Ratings of Biotech Stocks
Biogen Inc.
premium
premium
Hold
premium
premium
Reiterated
Regeneron Pharmaceuticals
premium
premium
Hold
premium
premium
Reiterated
Moderna
premium
premium
Buy
premium
premium
Upgraded
Gilead Sciences
premium
premium
Hold
premium
premium
Reiterated
Amgen Inc
premium
premium
Hold
premium
premium
Reiterated
Biontech Se Sponsored Adr
premium
premium
Buy
premium
premium
Reiterated
IQVIA Holdings
premium
premium
Buy
premium
premium
Reiterated
Illumina
premium
premium
Buy
premium
premium
Reiterated
Mettler-toledo International
premium
premium
Buy
premium
premium
Upgraded
Vertex Pharmaceuticals Inc.
premium
premium
Hold
premium
premium
Reiterated
Most Recent Earnings of Biotech Stocks
Gilead Sciences
Aug 02, 2022
2022 (Q2)
1.87
-15.51% (-0.29)
Amgen
Aug 04, 2022
2022 (Q2)
4.38
6.16% (+0.27)
Vertex Pharmaceuticals
Aug 04, 2022
2022 (Q2)
3.11
15.76% (+0.49)
Biogen
Jul 20, 2022
2022 (Q2)
5.68
-7.57% (-0.43)
Illumina
Aug 11, 2022
2022 (Q2)
1.87
-69.52% (-1.30)
Regeneron
Aug 03, 2022
2022 (Q2)
25.8
-62.13% (-16.03)
Moderna
Aug 03, 2022
2022 (Q2)
6.46
-18.89% (-1.22)
IQVIA Holdings
Jul 21, 2022
2022 (Q2)
2.13
14.55% (+0.31)
Mettler-Toledo
Jul 28, 2022
2022 (Q2)
8.1
15.93% (+1.29)
BioNTech SE
Aug 08, 2022
2022 (Q2)
10.436
-40.11% (-4.19)
Biotech Stocks - FAQ
Which Biotech stocks have a "Strong Buy" analyst rating?
These Biotech stocks currently have a "Strong Buy" analyst rating consensus:
IQVIA Holdings - Strong Buy, based on 12 analyst ratings, 12 Buy, 0 Hold, and 0 Sell.
Are Biotech stocks overpriced?
Gilead Sciences's stock price is currently $62.86, and its average 12-month price target is $72.43.
Amgen's stock price is currently $226.97, and its average 12-month price target is $235.40.
Vertex Pharmaceuticals's stock price is currently $283.45, and its average 12-month price target is $299.00.
Biogen's stock price is currently $197.78, and its average 12-month price target is $232.53.
Illumina's stock price is currently $190.38, and its average 12-month price target is $252.92.
Regeneron's stock price is currently $697.33, and its average 12-month price target is $760.67.
Moderna's stock price is currently $123.64, and its average 12-month price target is $214.63.
IQVIA Holdings's stock price is currently $189.43, and its average 12-month price target is $270.50.
Mettler-Toledo's stock price is currently $1,132.01, and its average 12-month price target is $1,314.20.
BioNTech SE's stock price is currently $128.35, and its average 12-month price target is $211.00.
Which Biotech stocks pay dividends?
Gilead Sciences does not currently pay dividends.
Amgen does not currently pay dividends.
Vertex Pharmaceuticals does not currently pay dividends.
Biogen does not currently pay dividends.
Illumina does not currently pay dividends.
Regeneron does not currently pay dividends.
Moderna does not currently pay dividends.
IQVIA Holdings does not currently pay dividends.
Mettler-Toledo does not currently pay dividends.
BioNTech SE does not currently pay dividends.
Popular Stock Comparisons
5g StocksAirline StocksARKK ETF Top HoldingsArtificial Intelligence StocksBank StocksBiotech StocksBitcoin StocksBlockchain StocksBlue Chip StocksCannabis StocksCasino StocksChinese StocksCloud & Storage StocksCryptocurrency StocksCybersecurity StocksDividend StocksElectric Vehicle StocksEnergy StocksFAANG StocksGold StocksGreen Energy StocksGrowth StocksHealthcare StocksHotel StocksLarge Cap StocksMATANA StocksMega Cap StocksMetaverse StocksNFT StocksOil StocksRussia-Ukraine War Affected StocksSocial Media StocksSolar StocksSpace StocksTech StocksUtility StocksValue StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks
Latest News
Biotech Stock Events
Biogen
Earnings Release
Oct 25, 2022
Illumina
Earnings Release
Oct 25, 2022
IQVIA Holdings
Earnings Release
Oct 26, 2022
Gilead Sciences
Earnings Release
Oct 27, 2022
Amgen
Earnings Release
Nov 01, 2022